Evaluation and Option Agreement for a Patent License Sample Contracts

Evaluation and Option Agreement for a Patent License

Evaluation and Option Agreement for a Patent License • April 2nd, 2018 • Argos Therapeutics Inc • Pharmaceutical preparations • England and Wales

• Contract Type
  Evaluation and Option Agreement for a Patent License
• Filed
  April 2nd, 2018
• Company
  Argos Therapeutics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  England and Wales

This Evaluation and Option Agreement for a Patent License ("Agreement"), dated as of February 1, 2018 ("Effective Date"), is by and between Actigen Limited (“Patent Holder”) Pharmstandard International, S.A. ("Prospective Licensor") and Argos Therapeutics, Inc. ("Prospective Sublicensee").